Diagnostic performance of the noninvasive prenatal FetoGnost RhD assay for the prediction of the fetal RhD blood group status

ConclusionNIPT RhD results are reliable when obtained with FetoGnost RhD assay. Targeted routine anti-D-prophylaxis can start as early as 11  + 0 weeks of gestation in singleton and multiple pregnancies.
Source: Archives of Gynecology and Obstetrics - Category: OBGYN Source Type: research